<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The administration of AOCED in the diets resulted in plasma DHA and EPA increases in maternal dogs after four weeks of feeding (GD 28) and continued feeding until the end of lactation period (
 <xref ref-type="fig" rid="pone.0217794.g005" class="xref">Fig 5</xref>). No baseline differences in plasma DHA and EPA concentrations were observed among the groups (Pretreat in 
 <xref ref-type="fig" rid="pone.0217794.g005" class="xref">Fig 5</xref>). Significant plasma DHA increases were observed in all test diet groups at both GD 28 and PPD 56 compared to that in the control group, but differences between dose groups did not reach statistical significance (
 <xref ref-type="fig" rid="pone.0217794.g005" class="xref">Fig 5A</xref>). Plasma EPA increases were more dose-dependent, as their levels in the mid- and high-dose groups were higher than those in the low-dose at GD 28 and with a clear dose-response at PPD 56 (
 <xref ref-type="fig" rid="pone.0217794.g005" class="xref">Fig 5B</xref>).
</p>
